Midsagittal image of the anatomy of sexual intercourse, from BMJ http://bit.ly/v2ZkxQ
Yesterday we reported on the retraction for data misuse and plagiarism of a
21-year-old paper on sex and female cancer patients. Turns out we missed a couple of rather interesting details about the authors of the pulled article.
One tidbit, for example, is that one of them, Willibrord Weijmar Schultz, is science royalty, having been a member of a team that won the 2000 Ig Nobel prize in medicine. Their heralded study, “
Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal,” published in 1999 in the BMJ: An inside-the-MRI look at the human body having sex. Continue reading Authors of retracted sex paper won Ig Nobel for MRI study of coitus — and had another retraction
Less than 24 hours after the publication of a study showing no link between XMRV, aka xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS), the authors of a a study claiming a link between the virus and prostate cancer have has been retracted it. The move comes along with the publication of a new study showing that no such link exists.
notice, from PLoS Pathogens: Continue reading Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted
Laurence Klotz, a prominent urologist at the University of Toronto who studies the prostate specific antigen (PSA), has corrected a paper after reusing his own words from an earlier review.
the correction, from the Journal of Clinical Oncology (JCO): Continue reading Duplication earns highly cited prostate cancer researcher a correction in JCO
Robert Getzenberg, the Johns Hopkins prostate cancer researcher who has recently retracted two papers involved in work he was sued over, has left the university, Retraction Watch has learned.
Getzenberg, who directed the Research Laboratories at the Hopkins’ Brady Urological Institute, has been working on an alternative to the prostate-specific antigen (PSA) test. In 2009, he — along with Hopkins and Pitt, his former employer — was
sued by a company that funded his work, Science magazine reported at the time. The suits were eventually settled for an undisclosed amount, and Getzenberg and his colleagues have now retracted two papers, one in Urology and one in The Prostate, as we’ve reported. Continue reading Prostate cancer researcher who retracted two studies at center of lawsuit departs Hopkins
If you’re a rabbit and you haven’t figured out where to carry your cell phone, your front pocket is just fine.
That’s what you could reasonably infer from the retraction of a paper in the
International Journal of Andrology purporting to show that mobile phones affected rabbits’ sperm counts. The notice, signed by the journal’s editor, Ewa Rajpert-De Meyts (we added links): Continue reading Rabbits needn’t worry about cell phones’ effects on their sperm count, say three retractions
Last week’s big Retraction Watch news — which got us quoted in the — was a New York Times Nature paper by Amy Wagers and Shane Mayack. The now-retracted paper suggested that the aging of stem cells could be reversed, and Blood has issued a notice of concern about a second paper.
Now comes news about another stem cell finding. The
International Journal of Urology has retracted a 2009 paper by Japanese researchers who claimed to have used stem cells derived from fatty tissue to treat urinary incontinence in two men. The men had developed bladder problems after undergoing surgery to remove their cancerous prostates.
According to the editor’s note, the article
Continue reading Another stem cell paper retracted, for “breach of established ethical guidelines”